首页> 外文会议>International Conference on Neuroprotective Agents: Clinical and Experimental Aspects >Treatment of Neurodegenerative Disorders with Radical Nanomedicine
【24h】

Treatment of Neurodegenerative Disorders with Radical Nanomedicine

机译:用自由基纳米胺治疗神经变性疾病

获取原文

摘要

In engineering and materials science, nanotechnology has provided many advances that effectively reduce oxidative damage generated by free radical production. Despite such advances, there has been little application to biomedical problems. Increased oxidative stress and free radical production are associated with neurodegenerative conditions, including aging, trauma, Alzheimer's and Parkinson's diseases, and many others. The antioxidant properties of cerium oxide nanoparticles show promise in the treatment of such diseases. Here, we summarize the work on the biological antioxidant actions of cerium oxide nanoparticles in extension of cell and organism longevity, protection against free radical insult, and protection against trauma-induced neuronal damage. We discuss establishment of effective dosing parameters, along with the physicochemical properties that regulate the pharmacological action of these new nanomaterials. Taken together, these studies suggest that nanotechnology can take pharmacological treatment to a new level, with a novel generation of nanopharmaceuticals.
机译:在工程和材料科学中,纳米技术提供了许多进展,从而有效地减少了自由基产生产生的氧化损伤。尽管存在此类进步,但对生物医学问题几乎没有应用。增加的氧化应激和自由基产生与神经变性条件相关,包括老化,创伤,阿尔茨海默氏菌和帕金森病,以及许多其他人。氧化铈纳米粒子的抗氧化性能显示治疗此类疾病的承诺。在这里,我们总结了氧化铈纳米颗粒的生物抗氧化作用在细胞和生物寿命的延伸中的生物抗氧化作用,防止自由基损伤的保护,以及免受创伤诱导的神经元损伤的保护。我们讨论建立有效的给药参数,以及调节这些新型纳米材料的药理作用的物理化学性质。这些研究表明,纳米技术可以将药理学治疗达到新的水平,具有新的纳米药品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号